LUKASZ SZARPAK to Depressive Disorder, Major
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Depressive Disorder, Major.
Connection Strength
0.329
-
Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials. Psychiatry Res. 2025 Feb; 344:116337.
Score: 0.167
-
Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder. Eur Neuropsychopharmacol. 2024 Sep; 86:18-19.
Score: 0.162